Novel Bispecific Antibody Tovecimig Shows Efficacy in Biliary Tract Cancer, Though Survival Benefit Remains Ambiguous
By Medical News Desk October 24, 2026 In a significant development for the treatment of aggressive gastrointestinal malignancies, results from the phase II/III COMPANION-002 clinical trial have offered a nuanced…
The Great Equity Illusion: Why AI "Nationalization" Is More Bailout Than Benefit
In 2021, OpenAI CEO Sam Altman published a seminal essay titled "Moore’s Law for Everything." It painted a utopian vision of an abundant future where the cost of basic human…












